AU Patent

AU2013288231B2 — Pediatric oral liquid compositions containing Nepadutant

Assigned to Laboratorio Guidotti SpA · Expires 2017-06-15 · 9y expired

What this patent protects

Oral liquid pharmaceutical compositions containing as active ingredient Nepadutant, PGS as solubilizer and optionally a chelating agent. Such compositions are found to be very stable and suitable for paediatric use in the treatment of gastro-intestinal diseases.

USPTO Abstract

Oral liquid pharmaceutical compositions containing as active ingredient Nepadutant, PGS as solubilizer and optionally a chelating agent. Such compositions are found to be very stable and suitable for paediatric use in the treatment of gastro-intestinal diseases.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013288231B2
Jurisdiction
AU
Classification
—
Expires
2017-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Laboratorio Guidotti SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.